FOGHORN THERAPEUTICS INC (FHTX)

US3441741077 - Common Stock

4.91  -0.6 (-10.89%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to FHTX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 16.32. This target is 232.38% above the current price.
FHTX was analyzed by 13 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about FHTX.
In the previous month the buy percentage consensus was at a similar level.
FHTX was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 4.919.0917.3416.3221.00 - 85.13% 253.16% 232.38% 327.70%
Up and Down Grades
Date Firm Action Rating
2024-12-17 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-16 Jefferies Maintains Buy -> Buy
2024-09-24 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2024-09-03 Jefferies Initiate Buy
2024-08-19 Evercore ISI Group Initiate Outperform
2024-08-12 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-09 Wedbush Reiterate Outperform -> Outperform
2024-05-07 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-01 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-10 Wedbush Reiterate Outperform -> Outperform
2024-04-10 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-08 Wedbush Reiterate Outperform -> Outperform
2023-11-13 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-08-07 HC Wainwright & Co. Reiterate Buy -> Buy
2023-07-06 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-06-29 Goldman Sachs Maintains Buy -> Buy
2023-06-28 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-08 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-09 Wedbush Maintains Outperform
2023-05-09 HC Wainwright & Co. Maintains Buy
2023-04-25 BMO Capital Maintains Outperform
2023-04-25 Wedbush Maintains Outperform
2023-03-28 B of A Securities Initiate Buy
2023-03-10 Wedbush Maintains Outperform
2023-03-10 HC Wainwright & Co. Reiterate Buy
2023-01-05 BMO Capital Initiate Outperform
2022-11-21 Morgan Stanley Maintains Equal-Weight
2022-08-24 Morgan Stanley Downgrade Overweight -> Equal-Weight
2022-08-10 HC Wainwright & Co. Maintains Buy
2022-05-24 Goldman Sachs Maintains Buy